| Literature DB >> 25453029 |
Sophie Delaigue1, Jean-Jacques Morand2, David Olson3, Richard Wootton4, Laurent Bonnardot5.
Abstract
INTRODUCTION: In 2010, Médecins Sans Frontières (MSF) launched a tele-expertise system to improve the access to specialized clinical support for its field health workers. Among medical specialties, dermatology is the second most commonly requested type of tele-expertise. The aim of the present study was to review all MSF teledermatology cases in the first 4 years of operation. Our hypothesis was that the review would enable the identification of key areas for improvement in the current MSF teledermatology system.Entities:
Keywords: LMICs; dermatology; low-resource settings; telehealth; telemedicine
Year: 2014 PMID: 25453029 PMCID: PMC4231841 DOI: 10.3389/fpubh.2014.00233
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Five areas of telemedicine as defined in the French public health code [2].
| Area | Comment |
|---|---|
| Teleconsultation | Consultation at distance between a doctor and a patient |
| Tele-assistance | Doctor assists another health professional in performing specific procedure |
| Telemonitoring | Doctor interprets at distance patient data |
| Medical emergency call center | Triage of calls from the general public, usually by telephone |
| Tele-expertise | Dialog between treating doctor and a specialist |
(A) Specialist responses (response rate 13/26 = 50%), (B) referrer responses (response rate 9/22 = 41%).
| Q1. Was the information (including any images) supplied by the referrer adequate? | Yes | No | Skipped | ||
| 8 (62%) | 5 (38%) | 0 | |||
| Q2. Was the information about the hospital available on the website (number of doctor, tests)? | Absent | Not sufficient | Sufficient | Easily accessible and complete | 1 |
| 2 (15%) | 5 (38%) | 5 (38%) | 0 | ||
| Q3. Did you receive any follow-up information about this patient? | Yes | No | 0 | ||
| 1 (7%) | 12 (93%) | ||||
| Q4. Do you think that feedback about the patient is? | Optional | Desirable | Necessary | Mandatory | 0 |
| 1 (7%) | 3 (23%) | 4 (31%) | 5 (39%) | ||
| Q5. Generally speaking how would you rate your satisfaction of the system on scale from 1 to 10? | Average rating | 0 | |||
| 6.37 | |||||
| Q6. In your opinion, which area(s) of improvement could be fruitful to the MSF teledermatology system? | Establishing formalized guidance for users | Implement a compulsory follow-up process | Conceiving standardized teledermatology pre-filled forms | Request some picture standard | 1 |
| 4 | 8 | 7 | 6 | ||
| Q1. Have you ever personally used the system? | Yes | No | Skipped | ||
| 6 (67%) | 3 (33%) | 0 | |||
| Q2. Have you heard about any follow-up of that (these) case(s)? | Yes | No | 0 | ||
| 5 (56%) | 4 (44%) | ||||
| Q3. Do you think that feedback about the patient is | Optional | Desirable | Necessary | Mandatory | 0 |
| 0 | 4 | 4 | 1 | ||
| Q4. Do you think that it is for you? | Impossible | Difficult | Easy | Very easy | 1 |
| 1 | 3 | 4 | 0 | ||
| Q5. In your opinion when would it be relevant to receive a compulsory follow-up process? | After 1 week | After 2 weeks | After 1 month | After 3 months | 1 |
| 5 | 0 | 3 | 0 | ||
.
(A) Summary of specialist comments (open-ended questions), (B) summary of referrer comments (open-ended questions).
| Number of comments | |
|---|---|
| Lack of feedback about patient follow-up | 3 |
| Lack of information about the case (image, medical history) | 3 |
| Against any mandatory system follow-up | 1 |
| Annual meeting | 1 |
| Proposal to use other technology (e.g., SMS) | 1 |
| Lack of well-adapted answer | 1 |
| Lack of epidemiological knowledge of the country of residence | 1 |
| Lack of headquarters’ support in using the system | 1 |
Figure 1Number of clinical dermatology cases referred each year. The open symbols represent values extrapolated from part-year observations.
Figure 2Confirmed histoid leprosy.
Figure 4Neurofibromatosis.
Figure 5Countries of origin of the referrers (. The countries of origin of the referrers are shaded: light gray = 1 case, dark gray = 2–5 cases, black > 5 cases. The countries of origin of the specialists are shaded in blue, with the number of specialists for each country shown.
Figure 6Most common topics of the cases.
Figure 7Suspected pox virus infection.
Figure 8Dermatology history form.
Figure 9Dermatology photography recommendations.